Jalila Adnane

2.5k total citations
23 papers, 2.1k citations indexed

About

Jalila Adnane is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jalila Adnane has authored 23 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Jalila Adnane's work include Cancer-related Molecular Pathways (9 papers), Fibroblast Growth Factor Research (5 papers) and Cancer Research and Treatments (3 papers). Jalila Adnane is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Fibroblast Growth Factor Research (5 papers) and Cancer Research and Treatments (3 papers). Jalila Adnane collaborates with scholars based in United States, France and Italy. Jalila Adnane's co-authors include Saı̈d M. Sebti, Charles Theillet, Patrick Gaudray, Paul D. Robbins, Daniel Birnbaum, P Jeanteur, Zhaohui Shao, Saı̈d Sebti, J Simony-Lafontaine and Anne Pradines and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Oncogene.

In The Last Decade

Jalila Adnane

22 papers receiving 2.1k citations

Peers

Jalila Adnane
Constadina Arvanitis United States
Randall Schreck United States
Nila U. Parikh United States
Tijana Borovski Netherlands
Yoichiro Yamanaka United States
Chiping Qian United States
Ka Yin Kwong United States
Ray Somcio United States
Prudence A. E. Scott United Kingdom
Keith Orford United States
Constadina Arvanitis United States
Jalila Adnane
Citations per year, relative to Jalila Adnane Jalila Adnane (= 1×) peers Constadina Arvanitis

Countries citing papers authored by Jalila Adnane

Since Specialization
Citations

This map shows the geographic impact of Jalila Adnane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jalila Adnane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jalila Adnane more than expected).

Fields of papers citing papers by Jalila Adnane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jalila Adnane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jalila Adnane. The network helps show where Jalila Adnane may publish in the future.

Co-authorship network of co-authors of Jalila Adnane

This figure shows the co-authorship network connecting the top 25 collaborators of Jalila Adnane. A scholar is included among the top collaborators of Jalila Adnane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jalila Adnane. Jalila Adnane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wilhelm, Scott M., Jalila Adnane, Mark Lynch, et al.. (2009). Abstract B4: Regorafenib: a new oral multikinase inhibitor of angiogenic, stromal and oncogenic (receptor tyrosine) kinases with potent preclinical antitumor activity. Molecular Cancer Therapeutics. 8(12_Supplement). B4–B4. 2 indexed citations
2.
3.
Chang, Yong S., Jalila Adnane, Pamela A. Trail, et al.. (2006). Sorafenib (BAY 43-9006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Cancer Chemotherapy and Pharmacology. 59(5). 561–574. 388 indexed citations
4.
Jackson, Rosalind J., et al.. (2002). Loss of the cell cycle inhibitors p21Cip1 and p27Kip1 enhances tumorigenesis in knockout mouse models. Oncogene. 21(55). 8486–8497. 66 indexed citations
5.
Adnane, Jalila, et al.. (2002). RhoB, Not RhoA, Represses the Transcription of the Transforming Growth Factor β Type II Receptor by a Mechanism Involving Activator Protein 1. Journal of Biological Chemistry. 277(10). 8500–8507. 37 indexed citations
6.
Adnane, Jalila, Rosalind J. Jackson, Santo V. Nicosia, et al.. (2000). Loss of p21WAF1/CIP1 accelerates Ras oncogenesis in a transgenic/knockout mammary cancer model. Oncogene. 19(47). 5338–5347. 79 indexed citations
7.
Chen, Zhi, Jiazhi Sun, Anne Pradines, et al.. (2000). Both Farnesylated and Geranylgeranylated RhoB Inhibit Malignant Transformation and Suppress Human Tumor Growth in Nude Mice. Journal of Biological Chemistry. 275(24). 17974–17978. 162 indexed citations
8.
Adnane, Jalila, Zhi Chen, Junko Ohkanda, et al.. (2000). Inhibition of farnesyltransferase increases TGFβ type II receptor expression and enhances the responsiveness of human cancer cells to TGFβ. Oncogene. 19(48). 5525–5533. 19 indexed citations
9.
Turkson, James, Tammy Bowman, Jalila Adnane, et al.. (1999). Requirement for Ras/Rac1-Mediated p38 and c-Jun N-Terminal Kinase Signaling in Stat3 Transcriptional Activity Induced by the Src Oncoprotein. Molecular and Cellular Biology. 19(11). 7519–7528. 226 indexed citations
10.
Adnane, Jalila, Zhaohui Shao, & Paul D. Robbins. (1999). Cyclin D1 Associates with the TBP-associated factor TAFII250 to regulate Sp1-mediated transcription. Oncogene. 18(1). 239–247. 55 indexed citations
11.
12.
Adnane, Jalila, Zhaohui Shao, & Paul D. Robbins. (1995). The Retinoblastoma Susceptibility Gene Product Represses Transcription When Directly Bound to the Promoter. Journal of Biological Chemistry. 270(15). 8837–8843. 103 indexed citations
13.
Robbins, Paul D., et al.. (1995). Transcriptional Regulation by the Retinoblastoma Tumor Suppressor Protein. Molecules and Cells. 5(6). 529–538. 3 indexed citations
14.
Adnane, Jalila & Paul D. Robbins. (1995). The retinoblastoma susceptibility gene product regulates Myc-mediated transcription.. PubMed. 10(2). 381–7. 17 indexed citations
15.
Theillet, Charles, José Adélaı̈de, Geneviève Louason, et al.. (1993). FGFRI and PLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers. Genes Chromosomes and Cancer. 7(4). 219–226. 131 indexed citations
16.
Birnbaum, Daniel, Odile deLapeyrière, Jalila Adnane, et al.. (1991). Role of FGFs and FGF Receptors in Human Carcinogenesis. Annals of the New York Academy of Sciences. 638(1). 409–411. 11 indexed citations
17.
Adnane, Jalila, Patrick Gaudray, Gregg Crumley, et al.. (1991). BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.. PubMed. 6(4). 659–63. 201 indexed citations
18.
Adnane, Jalila, Patrick Gaudray, Marie‐Pierre Simon, et al.. (1990). Proto-oncogene amplification and human breast tumor phenotype. Trends in Genetics. 6(11). 4–4. 134 indexed citations
19.
Theillet, Charles, de Lapeyrière O, Jalila Adnane, et al.. (1989). Amplification of FGF-related genes in human tumors: possible involvement of HST in breast carcinomas.. PubMed. 4(7). 915–22. 123 indexed citations
20.
Adnane, Jalila. (1989). Protooncogene amplification and human breasttumos phenotype. Medical Entomology and Zoology. 4. 1389–1397.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Constadina Arvanitis Breakdown of academic impact, for papers by Randall Schreck Breakdown of academic impact, for papers by Nila U. Parikh Breakdown of academic impact, for papers by Tijana Borovski Breakdown of academic impact, for papers by Yoichiro Yamanaka Breakdown of academic impact, for papers by Chiping Qian Breakdown of academic impact, for papers by Ka Yin Kwong Breakdown of academic impact, for papers by Ray Somcio Breakdown of academic impact, for papers by Prudence A. E. Scott Breakdown of academic impact, for papers by Keith Orford
Rankless by CCL
2026